DNA repair gene XRCC1 polymorphisms and outcome of renal cell carcinoma in caucasian patients

Anticancer Research

Volumn 29, Issue 12, 2009, Pages 5131-5135

  Bachmann, Hagen S ^a   Rübben, Herbert ^a   Schmid, Kurt W ^a   Siffert, Winfried ^a   Riemann, Kathrin ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

DNA repair; Genetic polymorphism; Haplotype; Outcome; Renal cell cancer; XRCC1

Indexed keywords

XRCC1 PROTEIN;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CAUCASIAN; CONTROLLED STUDY; DNA REPAIR; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; PATHOLOGY; PREDICTOR VARIABLE; PRIORITY JOURNAL; RISK FACTOR; TIME PERCEPTION; TREATMENT OUTCOME;

CARCINOMA, RENAL CELL; CASE-CONTROL STUDIES; DISEASE PROGRESSION; DNA REPAIR; DNA-BINDING PROTEINS; FEMALE; GENOTYPE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 75149128076     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Hoeijmakers JH: Genome maintenance mechanisms for preventing cancer. Nature 411: 366-374, 2001.
2. Kraemer KH, Levy DD, Parris CN, Gozukara EM, Moriwaki S, Adelberg S and Seidman MM: Xeroderma pigmentosum and related disorders: examining the linkage between defective DNA repair and cancer. J Invest Dermatol 103: 96S-101S, 1994.
3. Thompson LH, Brookman KW, Jones NJ, Allen SA and Carrano AV: Molecular cloning of the human XRCC1 gene, which corrects defective DNA strand break repair and sister chromatid exchange. Mol Cell Biol 10: 6160-6171, 1990.
4. Shen MR, Zdzienicka MZ, Mohrenweiser H,Thompson LH and Thelen MP: Mutations in hamster single-strand break repair gene XRCC1 causing defective DNA repair. Nucleic Acids Res 26: 1032-1037, 1998.
5. Shen MR, Jones IM and Mohrenweiser H: Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res 58: 604-608, 1998.
6. Hung RJ, Hall J, Brennan P and Boffetta P: Genetic polymorphisms in the base excision repair pathway and cancer risk: a HuGE review. Am J Epidemiol 162: 925-942, 2005.
7. Deligezer U, Akisik EE and Dalay N: Lack of association of XRCC1 codon 399Gln polymorphism with chronic myelogenous leukemia. Anticancer Res 27: 2453-2456, 2007.
8. Narter KF, Ergen A, Agachan B, Gormus U, Timirci O and Isbir T: Bladder cancer and polymorphisms of DNA repair genes (XRCC1, XRCC3, XPD, XPG, APE1, hOGG1). Anticancer Res 29: 1389-1393, 2009.
9. Improta G, Sgambato A, Bianchino G, Zupa A, Grieco V, La TG, Traficante A and Cittadini A: Polymorphisms of the DNA repair genes XRCC1 and XRCC3 and risk of lung and colorectal cancer: a case control study in a Southern Italian population. Anticancer Res 28: 2941-2946, 2008.
10. Duell EJ, Wiencke JK, Cheng TJ, Varkonyi A, Zuo ZF, Ashok TD, Mark EJ, Wain JC, Christiani DC and Kelsey KT: Polymorphisms in the DNA repair genes XRCC1 and ERCC2 and biomarkers of DNA damage in human blood mononuclear cells. Carcinogenesis 21: 965-971, 2000.
11. Lunn RM, Langlois RG, Hsieh LL, Thompson CL and Bell DA: XRCC1 polymorphisms: effects on aflatoxin B1-DNA adducts and glycophorin A variant frequency. Cancer Res 59: 2557-2561, 1999.
12. Yoon SM, Hong YC, Park HJ, Lee JE, Kim SY, Kim JH, Lee SW, Park SY, Lee JS and Choi EK: The polymorphism and haplotypes of XRCC1 and survival of non-small cell lung cancer after radiotherapy. Int J Radiat Oncol Biol Phys 63: 885-891, 2005.
13. de las Penas R, Sanchez-Ronco M, Alberola V, Taron M, Camps C, Garcia-Carbonero R, Massuti B, Queralt C, Botia M, Garcia-Gomez R, Isla D, Cobo M, Santarpia M, Cecere F, Mendez P, Sanchez JJ and Rosell R: Polymorphisms in DNA repair genes modulate survival in cisplatin/gemcitabine-treated non-small cell lung cancer patients. Ann Oncol 17: 668-675, 2006.
14. Sreeja L, Syamala VS, Syamala V, Hariharan S, Raveendran PB, Vijayalekshmi RV, Madhavan J and Ankathil R: Prognostic importance of DNA repair gene polymorphisms of XRCC1 Arg399Gln and XPD Lys751Gln in lung cancer patients from India. J Cancer Res Clin Oncol 134: 645-652, 2008.
15. Li D, Li Y, Jiao L, Chang DZ, Beinart G, Wolff RA, Evans DB, Hassan MM and Abbruzzese JL: Effects of base excision repair gene polymorphisms on pancreatic cancer survival. Int J Cancer 120: 1748-1754, 2007.
16. Ritchie AW and Chisholm GD: The natural history of renal carcinoma. Semin Oncol 10: 390-400, 1983.
17. Senan S and Smit EF: Design of clinical trials of radiation combined with antiangiogenic therapy. Oncologist 12: 465-477, 2007.
18. Hirata H, Hinoda Y, Matsuyama H, Tanaka Y, Okayama N, Suehiro Y, Zhao H, Urakami S, Kawamoto K, Kawakami T, Igawa M, Naito K and Dahiya R: Polymorphisms of DNA repair genes are associated with renal cell carcinoma. Biochem Biophys Res Commun 342: 1058-1062, 2006.
19. Sakano S, Hinoda Y, Okayama N, Kawai Y, Korenaga Y, Eguchi S, Nagao K, Ohmi C and Naito K: The association of DNA repair gene polymorphisms with the development and progression of renal cell carcinoma. Ann Oncol 18: 1817-1827, 2007.
20. Frey UH, Lummen G, Jager T, Jockei KH, Schmid KW, Rubben H, Muller N, Siffert W and Eisenhardt A: The GNASl T393C polymorphism predicts survival in patients with clear cell renal cell carcinoma. Clin Cancer Res 12: 759-763, 2006.
21. Barrett JC, Fry B, Mailer J and Daly MJ: Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265, 2005.
22. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, Feuer EJ and Thun MJ: Cancer statistics, 2005. CA Cancer J Clin 55: 10-30, 2005.
23. Wild CP, Jiang YZ, Allen SJ, Jansen LA, Hall AJ and Montesano R: Aflatoxin-albumin adducts in human sera from different regions of the world. Carcinogenesis 11: 2271-2274, 1990.